Core Capabilities in Contract Research
The main focus of the centre is to develop innovative pharmaceutical formulation technologies and help commercial partners overcome challenging formulation problems.
Our pharmaceutical formulation development activities are focused on enhancing solubility, stability, compatibility and effectiveness of challenging active molecules with expertise in:
- Preformulation Analysis
- Pharmaceutical Formulation Development
- Poorly Soluble Drugs
- Melt Processing Technologies
- Process Analytical Technology and QbD
The centre offers expertise in enabling and proprietary technologies for pharmaceutical formulation including:
For in-depth process understanding the centre has a range of Process Analytical Technologies (PAT) including in-line NIR and Raman techniques and expertise in applying QbD approaches to process optimisation.
The centre has expertise in analytical chemistry and access to an impressive range of analytical equipment that enables researchers to comprehensively characterize and screen both active ingredients and excipients.
Our capabilities also cover development in:
- Transdermal formulation
- Controlled release systems
- Inhaled delivery
- Parenteral delivery systems
- Conventional solid dosage (granulation and tabletting)
Professor Anant Paradkar - Director
Dr Jason Jones - Business Development
T: +44-1274- 236193